-- monitor, joining us to talk about a visitor coming to new hampshire. very well known. he is former vice president, mike pence. guest: great to join you guys again. host: this isn't the first outside trip for the former vice president. he spoke in south carolina. what is the occasion in new hampshire? guest: he will be headlining the hillsborough county gop. it is one of the largest counties in new hampshire and one of the most powerful republican organizations. their annual lincoln-reagan awards dinner and fundraiser, a major fundraiser for the county party. it is also the first visit of what we consider it one of the potential 2024 republican presidential contenders in person in new hampshire. you could say tonight's event will kick off the 2024 cycle in new hampshire. >> we will take you live now to

today's covid-19 briefing. jeffrey: dr. fauci will discuss the latest science. we will leave some time for questions and answers at the end. president biden released a comprehensive strategy on his first day in office to marshall and wartime effort to defeat the pandemic. we have spent each and every day of the last 4.5 months to getting against that strategy. today i want to provide any update on the progress we are making. first, on efforts to get americans vaccinated as quickly, efficiently, and equitably as possible. second, on efforts to help combat the pandemic globally. here at home, we have built a best in class vaccination program. 63 percent of adult americans

have received a feast one shot. 52% of adult americans are fully vaccinated. 12 states have 70% of adults with at least one shot. that is an important milestone. in 28 states and the district of columbia, they have fully vaccinated 50% or more of their adult population. communities and states across the country, the pandemic is in retreat. since the president took office january 20, cases are down 90%. deaths are down 85%. our successful vaccination program is not just saving tens of thousands of lives, it is letting tens of millions of americans get back to living their lives. it is fair to say that we are far ahead where anyone thought we would be in our fight against the virus. importantly, we have secured

enough vaccine supply for all americans. this is a result of the president taking aggressive action, including through the use of the defense production act to mobilize the full force of u.s. vaccine manufacturing and production. because of those actions and the success of vaccine manufacturers , we are confident in our supply of authorized vaccines. as a result, we are moving the priority rating for astrazeneca, novavax, and some of. while many factors continue to make these vaccines, this will allow u.s.-based but is to supply these vaccine manufacturers to make their own decisions about which orders to fulfill first. for all of the progress we have made as a country, as the president reiterated today, we have millions of americans in need of protection.

communities are at risk because of low vaccination rates. here's the bottom line, if you are unvaccinated, you are still at risk of getting seriously ill or spreading the disease to others. to help get people -- as many people vaccinated as we can, we are kicking off a month of action and mobilizing an american effort, including new commitments to childcare providers to provide free, drop in childcare to allow parents to get vaccinated. extended hours at local pharmacies for vaccinations, including many pharmacies that will be open 24 hours every friday starting next week. commitments from the state and private sector to privatize vaccinations and celebrate our progress, including free beer for anyone over the age of 21 on july 4 courtesy of anheuser-busch.

the vice president is leading a "we can do this" vaccination tour. this will help reach millions of americans who still need protection against the virus, highlights of the ease of getting vaccinated, encourage vaccination, and energize and mobilizing grassroots vaccine education and outreach efforts. as the days get brighter and brighter at home, we are focused on driving progress to help the pandemic -- to help end the pandemic around the globe. it is both the right thing to do and an important step in protecting americans by helping to step out of the virus. the president has committed that the u.s. will be an arsenal of vaccines. our work on vaccine supply is guided by a three-part approach. first, having successfully secured enough supply of vaccine from -- for americans, we are

donating surplus u.s. vaccine supply and encouraging other countries with surplus supplies to do the same. in march, the u.s. shared over 4 million doses of our astrazeneca vaccine supply with canada and mexico. the president has announced the commitment to share a total of 80 million doses by the end of june. this is five times the number of doses any country is committed to sharing. these doses represent 13% of the total vaccines produced by the united states by the end of this month. we will continue to donate additional doses across the summer months as supply becomes available. at the same time, we know that won't be sufficient. the second part of our approach is working with u.s. manufacturers to vastly increase

the vaccine supply for the rest of the world in a way that creates jobs here at home. driven by the actions that have been taken to accelerate manufacturing and production in the u.s., pfizer and moderna have increased their capacity to increase vaccines for the world. the third part of our approach will have us work with our partner nations and pharmaceutical companies and other manufacturers to facilitate the kind of global vaccine manufacturing and production capacity capabilities that cannot only help the world beat this pandemic, but also prepare the world to respond to potential future threats. today we are outlining our framework for sharing with the world the first 25 million doses. to be clear, -- [no audio]

-- life-saving protection to the one million south koreans who have already signed up to get a shot. this is just the beginning. we expect a regular cadence of shipments around the world across the next several weeks. in the weeks ahead, working with the world's democracies, we will create a multilateral effort to

combat the pandemic. let me turn over to jake sullivan. jake: today we are announcing our plan for sharing the first 25 million u.s. vaccines with the world. i will outline why we are saying them, how we are sharing them, and where we will share them. first, our goal in sharing our vaccines is in service in ending the pandemic. our overarching aim is to get as many safe and effective vaccines to as many people as possible as fast as possible. it is as simple as that. perhaps most important, this is

the right thing to do thanks to the ingenuity of american scientists and the resilience and commitment to the american people, we are in a position to help others so we will help others. as the president has said, the u.s. will not use is vaccines to secure favors from other countries. next, i want to say little about how we are sharing. we have received requests from all over the world and a number of important factors went into our decision about how to allocate these accidents. this included achieving global coverage, responding to surges and other urgent situations in public health needs, and helping as many countries as possible who requested vaccines. we have decided to prioritize helping our neighbors. we made the decision to share at least 75% of these vaccines through covax. this will maximize the number of

vaccines available equitably for all countries and will facilitate sharing with those at risk. and we decided to share up to 25% of these vaccines for immediate needs and to help around the world. we can share these 25% in a flexible way. finally, i want to talk about where we are sharing these first 25 million doses. we are sharing them in a wide range of countries within latin america and the caribbean, south and southeast east asia, and across africa in coronation with the african union. this includes prioritizing our neighbors in our hemisphere, including countries like guatemala and columbia, peru and ecuador, and many others. it respects existing regional networks for vaccine sharing like the platform of the african union and african centers for disease control and prevention and the regional health agency in the caribbean. these networks will help decide

where to allocate doses in regions with low vaccination rates and to those most at risk, including health care workers who have not yet gotten their shots. our approach prioritizes south and southeast asia, including countries like india, nepal, the philippines, and others undergoing surges. it recognizes our neighbors canada and mexico which received our first shared vaccines. and friends like the republic of korea where our military shares the command. it prioritizes other partners around the world, including countries with low vaccination rates who are dealing with urgent present crises like the west bank in gaza, ukraine, cozumel, iraq, haiti, and others. in the days ahead, we will work with covax and countries that will receive our vaccines.

as jeff has said, this is only the beginning. the president has committed to sharing doses on an ongoing basis, starting with 80 million by the end of june. we will continue to donate from our excess supply as it is delivered to us. we will work with our international partners to get ahead of the virus, to follow the science, and help countries in crisis. we also know this will not be enough to end or reduce the lifespan of the pandemic. that is why we are working with allies and partners to expand the production of vaccines and raw materials, including here at home as just described, and by building capacity around the world. we are also working with our g7 partners on a larger effort to help in the pandemic so that the world's democracies deliver for people everywhere. we will have more to say about this next week when he g7 leaders meet in the u.k. we will continue to build on existing health and health

security efforts focused on stopping the spread of covid-19, increasing vaccination, detecting outbreaks, responding to flares, and critically recovering economically here at home and around the world. we will do so in a way that strengthens our health institutions and our ability to come together as an international community to defeats not this -- not just this pandemic but the one after that. this is a unique moment in history and it requires american leadership, american science and ingenuity, american perseverance, and the world's democracies to stand up to the plate. i am proud to say that effort is underway. thanks. jeff: now over to dr. walensky. dr. walensky: good morning, it is great to be back with you. let's begin with an overview of the day. yesterday, cdc reported little over 900 -- 9300 new cases.

our 70 average is extinct cases per day. this represents a decrease of more than 30% from our prior 70 average and it is a 94% decrease from the peak of covid-19 cases reported in january this year. this is the type of news alike to deliver and this data is encouraging as we battle this pandemic. the 70 average of new hospital admissions is about 2750, a decrease of 80% in hospitalizations since january 9 this year where we peaked at an average of get is 16,500 daily hospital admissions. we can agree these trends are going in the right direction. the 70 average of david deaths has also declined to a new low of 363 per day, a decrease of more than 16% since last week. as the administration kicks off

its national month of action in the critical month of june, i want to highlight a specific population we are hoping will join the tens of millions who have already been vaccinated. that is as lessons -- that is adolescence. -- that is adolescents. the cdc has troubling data regarding the hospitalizations of adolescents with covid-19. more concerning where the number of adolescents admitted to the hospital who required treatment in the intensive care unit. tomorrow, we will publish a report with more details along with the more -- mortality report. it is within this publication, one that demonstrates the level of severe disease even among youth that are preventable, that force us to redouble our motivation to get out adolescents and young adults vaccinated.

last month, the fda authorized in the cdc recommended a safe and effective vaccine for covid-19 that can be used in adolescents to prevent disease and hospitalization. i encourage parents to get in their teens vaccinated as i did mine. if parents have questions or concerns, talk with your child's health care provider, your department of local pharmacist. until teams -- until teens are fully vaccinated, they should take precautions when around others who are not fully vaccinated to protect themselves, their friends. , and community. -- for their friends, and community. jeff: -- dr. fauci: i would like to spend a minute or so updating you in the arena of covid-19 therapeutics. the first slide that says selected therapeutics is broken up into three major components just to remind you that the work

that has been done over the past many months has been three separate approaches. one is to target the virus itself. as you can see, the number of interventions are listed there. the other is to moderate a response, moderating the host. the others are therapies such as anticoagulants. if we get to the red circle, that is what i want to bring to the attention of the audience. that is monoclonal antibodies, two of which are the regeneron combination and the eli lilly combination which have been approved. i highlighted an additional antibody made by gsk and vir. six days ago, some exciting data has been published.

that is a randomized placebo-controlled phase three trial of non-hospitalized patients with mild to moderate covid-19 who are at high risk for the progression of their disease, close to 600 people, a single dose of the monoclonal antibody by gsk and vir reduced the risk of hospitalization or death by 85% compared with the placebo. it is well and there are no safety signals identified. this antibody retains activity against multiple variants. what we have our three options within the arena of monoclonal antibodies, something that is important for physicians to know that there is an important option for treating people early

to prevent them from going to the hospital. this has been granted an eua so it is available for use and we encourage physicians to at least consider this possibility as part of your therapeutic. i will stop there and back to you, jeff. jeff: why don't we open it up for a few questions. >> we are running short on time so we will just take a couple of questions. please keep to just one question on topic. first, josh of bloomberg. >> thank you. can you hear me? jeff: i can hear you, josh. >> can you speak to which specific vaccines will be sent in the 25 million? i assume it is safe to say that the astrazeneca doses remain under review?

jeff: i think we are working on technical issues and hopefully we are able to open up for questions soon. >> jeff, let me know if you can hear me, please. i was wondering if you could say which vaccines will be sent among the 25 million. i assume astrazeneca doses remain under review? jeff: good question. that is correct. the astrazeneca doses, the 60 million doses are awaiting fda conference. a 25 million will be comprised of the three approved -- authorized vaccines, a combination of johnson & johnson, pfizer, and moderna.

next one. >> thanks so much, jeff. does the u.s. still have a final say where doses go or is it covax picking a decision? when will these 25 million distributed and are you confident the remaining 55 will be out by the end of june? jeff: jake, why don't i handed to you. -- why don't i hand it to you. jake: jeff, was that the question? jeff: yes. the question on covax, if you can handle that and i will take

the rest. jake: as i understand, the question is if the u.s. has the final say on where the doses are going shared through covax. the answer is that the u.s. working covax -- the u.s. has made selections against that -- so that we will retain the say as to where they go. in the case of the african union , we are sharing with the african union who will ultimately be making the determinations about how to allocate within africa. with the caribbean, we will be working with the public health authority in the caribbean who will be making some of the key determinations for where the doses are allocated. ultimately, the u.s. will have the authority to say that the doses are going here as opposed

to their. that will be done in close consultation with covax and according to covax's formula and using the covax logistics capacity and delivery capacity to ensure these doses translate into shots in arms that help save people's lives. jeff: the second part of the question -- [indiscernible] those doses are in flight now. we announced plans to share about 13% of the vaccines produced for the u.s. by the end of june. that is the most of any nation. over the coming weeks, we will work to get those doses to countries and get shots in arms as soon as possible. as we do so, we will work through logistics like medical

agencies coordinating to ensure safety and regulatory information to share supply, to make sure we have the necessary needles and syringes and alcohol pads. transportation to ensure proper temperature storage, prevent rickets, and make sure the vaccine immediately clears customs. the process to export the first 35 million is underway in association with foreign governments. the president has committed to sharing 80 million doses by the end of june and we will deliver on the president's commitment by the end of june. >> asked question and sorry for the technical challenges. cheryl at the new york times. >> thank you for taking my call. i wondered if you could be more specific about the 25% of doses you are reserving for immediate use, the flexible doses. where are they going?

jeff: over to jake. jake: technical difficulties persist, but the answer is that we will lay out more specifically the precise definition of those. the judgment we make about where those go is a combination of where there are urgent situations where partner countries are facing crises. some examples of that include -- a portion of those will go to india which has obviously dealt with a surge. we have seen the gripping images coming from that country.

some of them will go to the west bank and gaza which has endured its own crisis. there will be other destinations for the remaining doses. we will lay that out as those doses are prepared and shipped. jeff: next question. >> we will do one more question to zeke at ap. >> thank you. can you say where the doses are coming from? are they coming from states' inventory or the approval of federal supply? for jake, can you explain the president's guidance that there will be no strings attached to these vaccines -- [indiscernible]

why not just give it all to covax to be shared? jeff: on the first question, the 25 million doses are coming from the federal pool of supply. at the states levels, those states have ordered those so we are working to administer those insulting americans who have not been vaccinated can get vaccinated as soon as possible. jake: the united states is not asking anything of any country of whom we are giving doses. we are not extorting or asking concessions or imposing conditions the way other countries who are providing doses are doing. we are doing none of those things. these are doses being donated free and clear to these countries for the sole purpose of proving the public health situation. the korea situation is unique

because the president said that the animating purpose behind that is actually about the protection of american forces that serve alongside korean troops, standing shoulder to shoulder with us in that country. it is a unique case and the kind of unique case for which we went to we can flexibility which is why we are giving 75% or more of our doses through covax but maintaining the capacity to allocate doses outside the covax formula is necessary. the west bank and gaza is another case where we are not asking anything of the people of gaza or the west bank. we feel given what they are dealing with any situation on the ground, it is only right and proper and good for the united states to allocate some doses to that country. the same is true for other allocations we will make.

the president made a commitment to ensure india received doses, not just giving them any allocation under the regional portion of this, but an additional allocation from our discretionary portion. it is something he wanted to do. the basic bottom line is that the u.s. is not doing this as some kind of back and forth deal where we are getting from what we are giving. we are giving these for a single purpose. it is the purpose of ending this pandemic and we are doing so in a way consistent with the public health requirements that will hasten the end of the pandemic. jeff: we have time for one more. >> let's go to cbs.

>> thank you so much. my question is for dr. wilensky. as you watch this push for vaccinations ahead of july 4, this morning -- listed reasons why people may not be getting vaccinated yet. i am wondering if you are making educated guesses or have any data or figures to show why some people are still holding out, especially in the south where rates are relatively low? dr. fauci: jeff, i think rochelle got kicked out by her computer. jeff: [laughter] all americans -- so it is

important we answer questions about the safety and effectiveness of the vaccines. we know all three are very effective and safe but we needed to answer those questions. the good news is that confidence in the vaccines has grown across time as people have natures and -- have neighbors and friends and faith leaders and doctors who have been vaccinated and advise them. the important thing is that the most important -- the most trusted messengers are trusted doctors and faith leaders. we are confident more and more people will get vaccinated leading up to the fourth of july. should we try to do one more question, kevin? >> i think we have to wrap up, but thank you, jeff.

jeff, we can wrap up. >> c-span is your unfiltered view of government. we are funded by these television companies and more, including media,. -- including mediacom. >> we never slowed down, schools and businesses went virtual and we powered a new reality. as mediacom, we are built to keep you ahead. >>mediacom supports c-span service along with these other providers. >> our live coverage continues today at 1:00 p.m. eastern when the new deputy administrator for

the center of medicare and medicaid services, liz fowler, talks about the biden administration's plan for health care. this evening, mike pence is the featured speaker at the lincoln reagan dinner in manchester, new hampshire. you can find these life events online at c-span.org will listen with the free c-span radio app. tonight at 8:00 eastern, a look at a national paid family and medical leave program. experts and business representatives testified about the pandemic's disbursement -- pandemic's disproportionate effect on women and children. that is tonight on c-span. >> on sunday, the military historian and journalist max hastings will be our guest on in-depth. >> the 1975 fall of saigon inflicted humiliation upon the planet's most powerful nation.

revolutionaries prevailed over western wealth. the stairway on which fugitives ascended to a rooftop helicopter, secured a place among the symbolic images of that era. for me, as for all my generation , the struggle was among the foremost expenses of our careers. i was one of those who flew out of the u.s. embassy on that terrifying day. >>'s most recent book is "operation pedestal." other books include "catastrophe 1914," and "overlord." join in with your calls, comments, texts and tweets sunday afternoon eastern with max